Norix Group, Inc. v. Correctional Technologies, Inc.

CourtDistrict Court, N.D. Illinois
DecidedJanuary 19, 2021
Docket1:20-cv-01158
StatusUnknown

This text of Norix Group, Inc. v. Correctional Technologies, Inc. (Norix Group, Inc. v. Correctional Technologies, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Norix Group, Inc. v. Correctional Technologies, Inc., (N.D. Ill. 2021).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

NORIX GROUP, INC., ) ) Plaintiff, ) 20 C 1158 ) vs. ) Judge Gary Feinerman ) CORRECTIONAL TECHNOLOGIES, INC., d/b/a ) Cortech USA, and VDL INDUSTRIES, LLC, d/b/a ) American Shamrock, ) ) Defendants. )

MEMORANDUM OPINION AND ORDER Norix Group, Inc. brings this suit against Correctional Technologies, Inc. and VDL Industries, LLC (together, “Cortech”), alleging infringement of two Norix-owned patents, one relating to beds (the ’150 patent) and the other to shelving units (the ’642 patent). Doc. 14. Cortech moves to stay this case pending ex parte reexamination proceedings of the ’150 patent before the U.S. Patent and Trademark Office (“PTO”). Doc. 27. Cortech also moves under Civil Rule 12(b)(6) to dismiss Norix’s claim that it infringed the ’642 patent. Doc. 33. Cortech’s motion to stay is granted in part and denied in part, and its motion to dismiss is denied. Background In resolving a Rule 12(b)(6) motion, the court assumes the truth of the operative complaint’s well-pleaded factual allegations, though not its legal conclusions. See Zahn v. N. Am. Power & Gas, LLC, 815 F.3d 1082, 1087 (7th Cir. 2016). The court must also consider “documents attached to the complaint, documents that are critical to the complaint and referred to in it, and information that is subject to proper judicial notice,” along with additional facts set forth in Norix’s brief opposing dismissal, so long as those additional facts “are consistent with the pleadings.” Phillips v. Prudential Ins. Co. of Am., 714 F.3d 1017, 1020 (7th Cir. 2013) (internal quotation marks omitted). The facts are set forth as favorably to Norix as those materials allow. See Pierce v. Zoetis, Inc., 818 F.3d 274, 277 (7th Cir. 2016). In setting forth the facts at the pleading stage, the court does not vouch for their accuracy. See Goldberg v. United

States, 881 F.3d 529, 531 (7th Cir. 2018). Norix holds several patents relating to “intensive use” furniture, meaning furniture used in environments—such as jails, prisons, behavioral health care centers, and psychiatric facilities—in which traditional furniture poses health and safety risks. Doc. 14 at ¶¶ 8-9, 11. This case involves two of those patents. The first is the ’150 patent—U.S. Patent No. 10,507,150—which claims intensive use beds with “several innovative features, including support ridges on the side and end walls and mounting flanges in the outer shell.” Id. at ¶¶ 26- 27. The ’150 patent’s claims are embodied in Norix’s “Attenda Platform Bed” line. Id. at ¶¶ 38- 41. The second is the ’642 patent—U.S. Patent No. 10,575,642—which claims intensive use shelving units with “several innovative features, including a J-bar configuration hangar [sic]

support molded into the unit.” Id. at ¶¶ 30-31. The’642 patent’s claims are embodied in Norix’s “Attenda Wardrobe” line. Id. at ¶¶ 69-71. Like Norix, Cortech manufactures and sells intensive use furniture. Id. at ¶¶ 42-50, 72- 75. Norix’s original complaint alleged that Cortech’s “Endurance Series” line of beds infringes the ’150 patent. Doc. 1 at ¶ 1. Norix’s amended complaint adds a count alleging that Cortech’s “Endurance Series” line of shelving units infringes the ’642 patent. Doc. 14 at ¶¶ 114-125. After the amended complaint was filed, Cortech asked the PTO to initiate an ex parte reexamination of the ’150 patent, citing three publications that, according to Cortech, anticipated the ’150 patent. Doc. 27-1. After the PTO initiated the reexamination—which meant that it had “determine[d] [that] the request raise[d] ‘a substantial new question of patentability affecting any claim of the patent,’” Celgene Corp. v. Peter, 931 F.3d 1342, 1359 (Fed. Cir. 2019) (quoting 35 U.S.C. § 303(a))—Cortech moved this court to stay this suit pending the reexamination. Doc. 27. While the stay motion was pending, a PTO examiner rejected all the ’150 patent’s

claims as unpatentable in light of the prior art submitted by Cortech. Doc. 53-1. Discussion I. Motion to Dismiss Cortech makes three arguments to support dismissal of Norix’s claim alleging infringement of the ’642 patent. The first concerns an alleged defect in the patent application process. The patent application that ultimately yielded the ’642 patent claimed priority to several earlier applications. Doc. 14 at ¶¶ 14-29. Cortech contends that the application failed to comply with the procedures outlined in 35 U.S.C. § 120 and 37 C.F.R. § 1.78 because it did not include sufficient information about the previous applications. Doc. 33 at 7-10. And Cortech argues that “[t]he ’642 patent is currently unenforceable” in light of that alleged defect. Id. at 7. After Cortech moved to dismiss on this ground, Norix petitioned the PTO to correct the

’642 patent to include the information omitted from the application. Doc. 50-1. The PTO granted the petition and issued a certificate of correction confirming the change. Doc. 50-2. Likely anticipating that Norix would take this step, Cortech contends that Norix “cannot seek relief for any alleged infringement of the claims of that patent that allegedly occurred prior to the issuance of a certificate of correction because, prior to that date, the patent is not valid and enforceable.” Doc. 33 at 9 (emphases added). Even if Cortech is right that Norix may not recover damages for pre-correction infringement, the infringement claim still would survive as to Norix’s request for injunctive relief and damages to remedy Cortech’s alleged ongoing infringement. See E.I. du Pont de Nemours & Co. v. MacDermid Printing Sols., L.L.C., 525 F.3d 1353, 1362 (Fed. Cir. 2008) (explaining that a certificate of correction is effective even after an infringement suit is filed because “each act of infringement gives rise to a separate cause of action”). Cortech’s second argument is that its shelving units cannot possibly infringe the ’642

patent because all the patent’s claims refer to a “hangar” rather than a “hanger.” In everyday usage, a “hanger” is something used to hang clothes, Hanger, Webster’s Third New International Dictionary (1961) (def. 3c), while a “hangar” is a place for storing and repairing aircraft, Hangar, Webster’s Third New International Dictionary, supra (entry 1). Thus, argues Cortech, “the [patent’s] claims, as written, are absurd or nonsensical,” meaning that Norix’s infringement claims must be dismissed. Doc. 33 at 11. As principal support, Cortech cites Chef America, Inc. v. Lamb-Weston, Inc., 358 F.3d 1371 (Fed. Cir. 2004), a case involving a patent that claimed a process involving “heating … batter-coated dough to a temperature in the range of about 400° F. to 850° F.” Id. at 1372 (quoting the patent). The problem with the claim was that “if the batter-coated dough [were]

heated to a temperature range of 400° F. to 850° F., as the claim instructs, it would be burned to a crisp.” Id. at 1373.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Norix Group, Inc. v. Correctional Technologies, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/norix-group-inc-v-correctional-technologies-inc-ilnd-2021.